Results 111 to 120 of about 81,598 (300)
Several intracellular Leishmania antigens have been identified in order to find a potential vaccine capable of conferring long lasting protection against Leishmania infection. Histones and Acid Ribosomal proteins are already known to induce an effective immune response and have successfully been tested in the cutaneous leishmaniasis mouse model.
Lais Pereira +12 more
openaire +6 more sources
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Hoda Haghshenas +3 more
wiley +1 more source
ABSTRACT Background Currently, six species of Callithrix are frequently observed in anthropized and degraded environments in different regions of Brazil. This occupation favors interactions with humans and increases the risk of infection by parasites with zoonotic potential.
Maysa Emanuely dos Santos +3 more
wiley +1 more source
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis [PDF]
Previous studies demonstrated safety, immunogenicity and efficacy of DNA/modified vaccinia virus Ankara (MVA) prime/boost vaccines expressing tryparedoxin peroxidase (TRYP) and Leishmania homologue of the mammalian receptor for activated C kinase (LACK ...
Alcami, Antonio +7 more
core +1 more source
Visceral leishmaniasis patients display altered composition and maturity of neutrophils as well as impaired neutrophil effector functions [PDF]
Immunologically, active visceral leishmaniasis (VL) is characterised by profound immunosuppression, severe systemic inflammatory responses and an impaired capacity to control parasite replication.
Adem, E +19 more
core +3 more sources
. In India, visceral leishmaniasis (VL) caused by Leishmania donovani has been successfully treated with miltefosine with a cure rate of > 90%. To assess the efficacy and safety of oral miltefosine against Brazilian VL, which is caused by Leishmania ...
J. Carnielli +9 more
semanticscholar +1 more source
Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles
The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges +6 more
wiley +1 more source
Visceral leishmaniasis (VL) is an important parasitic disease which is endemic in different parts of Iran; and domestic and wild canines are principal reservoir hosts of the disease.
M. Mohebali, E. Moradi-Asl, Y. Rassi
semanticscholar +1 more source
ABSTRACT Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies, particularly in endemic regions.
Bahareh Abtahi‐Naeini +5 more
wiley +1 more source
Prevalence and Sequence Analysis of Vector‐Borne Zoonotic Diseases in Stray Cats in Istanbul
Istanbul, the largest metropolis in Türkiye, is home to a notable population of stray cats. While cats enrich the city's culture, they can also transmit various diseases, posing diagnostic challenges for clinicians. This study aimed to detect infections in stray cats using PCR and sequencing to identify Ehrlichia, Anaplasma, Bartonella, Hepatozoon ...
Tuba Yazicioglu, Handan Cetinkaya
wiley +1 more source

